I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Vleminckx, Camille
9
results:
Search for persons
X
Format
Online (9)
Mediatypes
Articles (Online) (7)
OpenAccess-fulltext (2)
Sorted by: Relevance
Sorted by: Year
?
1
Biomarker‐Driven Developments in the Context of the New Reg..:
Verbaanderd, Ciska
;
Trullás Jimeno, Ana
;
Engelbergs, Jörg
...
Clinical Pharmacology & Therapeutics. 114 (2023) 2 - p. 316-324 , 2023
Link:
https://doi.org/10.1002/..
?
2
Evolution of the EU Biosimilar Framework: Past and Future:
Wolff-Holz, Elena
;
Tiitso, Klara
;
Vleminckx, Camille
.
BioDrugs. 33 (2019) 6 - p. 621-634 , 2019
Link:
https://doi.org/10.1007/..
?
3
Reply to In support of the European Union biosimilar framew..:
Working Party on Similar Biological (Biosimilar) Medicinal Products (BMWP)
;
Schneider, Christian K
;
Borg, John J
...
Nature Biotechnology. 30 (2012) 8 - p. 748-749 , 2012
Link:
https://doi.org/10.1038/..
?
4
Setting the stage for biosimilar monoclonal antibodies:
Schneider, Christian K
;
Vleminckx, Camille
;
Gravanis, Iordanis
...
Nature Biotechnology. 30 (2012) 12 - p. 1179-1185 , 2012
Link:
https://doi.org/10.1038/..
?
5
In support of the European Union biosimilar framework:
Working Party on Similar Biological (Biosimilar) Medicinal Products (BMWP)
;
Schneider, Christian K
;
Borg, John J
...
Nature Biotechnology. 30 (2012) 8 - p. 745-748 , 2012
Link:
https://doi.org/10.1038/..
?
6
Biosimilars—why terminology matters:
Weise, Martina
;
Bielsky, Marie-Christine
;
De Smet, Karen
...
Nature Biotechnology. 29 (2011) 8 - p. 690-693 , 2011
Link:
https://doi.org/10.1038/..
?
7
Climate anomalies and neighbourhood crowding interact in sh..:
Nemetschek, Daniela
;
Derroire, Géraldine
;
Marcon, Eric
...
Journal of Ecology. 112 (2024) 3 - p. 590-612 , 2024
Link:
https://doi.org/10.1111/..
?
8
Climate anomalies and neighbourhood crowding interact in sh..:
Nemetschek, Daniela
;
Derroire, Géraldine
;
Marcon, Eric
...
info:eu-repo/semantics/altIdentifier/doi/10.1111/1365-2745.14256. , 2024
Link:
https://hal.inrae.fr/hal..
?
9
The persistence of carbon in the African forest understory:
Hubau, Wannes
;
De Mil, Tom
;
Van den Bulcke, Jan
...
https://e-space.mmu.ac.uk/624016/. , 2019
Link:
https://e-space.mmu.ac.u..
1-9